NAT Mini-Pool Is West Nile Blood Screen Priority, But IgM Role Is Uncertain
This article was originally published in The Gray Sheet
Executive Summary
FDA is recommending manufacturers of tests that could potentially be used to screen blood for West Nile Virus to pursue nucleic acid test mini-pooling, despite concerns with the procedure's sensitivity